Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6870.5000 -113.00 (-1.62%)
NSE Jul 10, 2025 14:50 PM
Volume: 124.6K
 

logo
Divi's Laboratories Ltd.
13 Aug 2022
6870.50
-1.62%
buy
by BOB Capital Markets Ltd.
Target: 4250
BOB Capital Markets Ltd.
Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below
 
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch | 10 Jul 2025, 02:49PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline | 10 Jul 2025, 12:14PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022, 06:14AM